Wolfe Research analyst Mike Polark downgrades Silk Road Medical (NASDAQ:SILK) from Outperform to Peer Perform.
Liquidia Technologies FY EPS $(0.67) Beats $(0.73) Estimate, Sales $15.94M Beat $12.80M Estimate
Liquidia Technologies (NASDAQ:LQDA) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.73) by 8.22 percent. This is a 4.29 percent increase over losses of $(0.70) per share
